Unigrel SR Tablet 300 mg (Sarpogrelate Hydrochloride)

Adult dose

Adult: Administer Sarpogrelate Hydrochloride sustained-release tablet 300 mg orally once daily after meals. Do not chew or crush this medication; take it whole.

This medication should not be used in patients with bleeding. It may worsen bleeding in conditions with a high risk of bleeding, such as hemophilia or gastrointestinal ulcers. Women who are pregnant or may become pregnant should avoid taking this medication due to reported negative effects on the fetus in animal studies. This medication contains lactose, so it should not be administered to patients with problems in lactose metabolism or galactose intolerance. Women during menstruation, patients with a tendency to bleed, and those taking anticoagulants or platelet aggregation inhibitors should use this medication with caution as the risk of bleeding may increase. Patients with severely impaired renal function or elderly patients should also exercise caution when using this medication due to its potential impact on drug excretion. While taking this medication, side effects such as dyspepsia, diarrhea, itching, cough, and peripheral edema may occur, and any symptoms should be discussed with a healthcare professional. Additionally, cardiovascular adverse reactions such as myocardial infarction or peripheral arterial stenosis have been reported rarely, so caution is needed. Regular blood tests are recommended during the course of medication to detect bleeding tendencies or abnormalities early. When taken in conjunction with anticoagulants or platelet aggregation inhibitors, the risk of bleeding may increase, so care is needed when used together. Breastfeeding women should also avoid taking this medication, and if unavoidable, it is advisable to discontinue breastfeeding. Safety for children has not been established, so it is recommended not to use this medication in pediatric patients. Finally, this medication should be stored out of reach of children, and transferring it to another container may compromise its quality, so caution is advised.

Serious side effects

Urticaria, severe swelling (edema), tightness in the chest, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin peeling, pain of oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue throughout the body, sudden and very severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urine

Mild side effects

• Sensory impairment
• hypersomnia
• dyspepsia
• diarrhea
• itching
• pneumonia
• increased blood creatinine
• hypertriglyceridemia
• flank pain
• herniated disc

This medication should be stored in a sealed container to protect it from air and moisture, and it is safe to store it at room temperature between 1°C and 30°C. Maintaining appropriate temperature and container conditions will help preserve the medication's effectiveness and safety for a long time.

Appearance

White oblong film-coated sustained-release tablet

Package unit

For domestic use - 100 tablets/bottle, For domestic use - 30 tablets/bottle, For export - 30 tablets/box [(10 tablets/PTP X 3)]